Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Type C Meeting Timings

<< Previous

Bullboard Posts

Next >>

Comment by Quentin30on May 09, 2024 10:12am

71 Views

Post# 36030967

RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings

And you KNOW about ONCY's intent... because...??

1) Your paymasters have told you what their INTENT is ?
2) You use such language to sound authoritative ?
3) ONCY's PPS has cratered 60+% in the 3-4 years since they have been paying your for your fluff pieces?

Noteable - UNLESS you are an insider... YOu actually have no more clue about ONCY's intent, than anyone else on this bb...

No need to be such a loser like Azzak.

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets